Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer

Condition:   Breast Cancer Interventions:   Drug: Fluzoparib;   Drug: Anastrozole;   Drug: Letrozole;   Drug: Exemestane;   Drug: Tamoxifen;   Drug: Toremifene;   Drug: Abemaciclib;   Drug: LHRH agonist Sponsor:   Fudan University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials